## **Core Concept**
Lymphoplasmacytoid lymphoma, also known as Waldenström's macroglobulinemia, is a type of non-Hodgkin lymphoma characterized by the presence of lymphoplasmacytoid cells in the bone marrow. This condition is associated with specific cytogenetic abnormalities that contribute to its pathogenesis. Understanding these abnormalities is crucial for diagnosis and management.

## **Why the Correct Answer is Right**
The correct answer, **t(9;14)**, involves the PAX5 and WHSC1 genes. This translocation is characteristic of lymphoplasmacytoid lymphoma/Waldenström's macroglobulinemia. The **PAX5** gene is crucial for B-cell development and is often implicated in B-cell malignancies. The **WHSC1** gene, also known as **MMSET**, is involved in transcriptional regulation and is associated with myeloma and lymphomas. This translocation leads to the overexpression of **WHSC1**, contributing to lymphomagenesis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **t(11;18)** is a significant translocation in marginal zone lymphoma, particularly in MALT lymphoma, it is not specifically associated with lymphoplasmacytoid lymphoma. This translocation involves the **API2** and **MALT1** genes.
- **Option B:** **t(14;18)** is commonly associated with follicular lymphoma, involving the **BCL2** gene, and is not specific to lymphoplasmacytoid lymphoma.
- **Option D:** **t(8;14)** is characteristic of Burkitt lymphoma, involving the **MYC** oncogene, and is not associated with lymphoplasmacytoid lymphoma.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that Waldenström's macroglobulinemia often presents with hyperviscosity syndrome due to the high levels of IgM paraprotein. Patients may exhibit symptoms such as visual disturbances, headaches, and fatigue. The association of **t(9;14)** with this condition is a critical piece of information for hematopathologists and oncologists.

## **Correct Answer:** . t(9;14)